38710 Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices 

Planning Grant (R34) and Implementation 

Cooperative Agreement (U01). 

Date: August 28, 2018. 

Time: 10:00 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Louis A. Rosenthal, Ph.D., 

Scientific Review Officer Scientific Review 

Program, Division of Extramural Activities, 

Rm. 3G42B, National Institutes of Health/ 

NIAID, 5601 Fishers Lane, MSC 9834, 

Bethesda, MD 20892–9834, (240) 669–5070, 

rosenthalla@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: August 1, 2018. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16789 Filed 8–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Clinical and Translational Exploratory/ 

Developmental Studies. 

Date: September 14, 2018. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin Arlington Gateway, 801 

North Glebe Road, Arlington, VA 22203. 

Contact Person: Robert S. Coyne, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W236, Bethesda, MD 

20892–9750, 240–276–7684, coyners@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–7: NCI 

Clinical and Translational R21 and Omnibus 

R03. 

Date: September 27, 2018. 

Time: 7:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Saejeong J. Kim, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W640, Bethesda, MD 

20892–9750, 240–276–5179, saejeong.kim@

nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group, Subcommittee 

J—Career Development. 

Date: October 11–12, 2018. 

Time: 5:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard Bethesda, MD 20817. 

Contact Person: Tushar Deb, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W624, Bethesda, MD 20892–9750, 

240–276–6132, tushar.deb@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Innovative 

Molecular and Cellular Analysis 

Technologies (IMAT). 

Date: October 19, 2018. 

Time: 8:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

2E908, Rockville, MD 20850. 

Contact Person: Yasuko Furumoto, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W634, Bethesda, MD 20892– 

9750, 240–276–5287, yasuko.furumoto@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; R25 

Review. 

Date: October 24, 2018. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W110, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Robert E. Bird, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W110, Bethesda, MD 20892–9750, 

240–276–6344, birdr@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Innovative 

Molecular Analysis Technologies (IMAT). 

Date: November 1, 2018. 

Time: 11:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W634, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Yasuko Furumoto, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W634, Bethesda, MD 20892– 

9750, 240–276–5287, yasuko.furumoto@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; UH2/UH3 

Review. 

Date: November 7, 2018. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W110, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Robert E. Bird, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W110, Bethesda, MD 20892–9750, 

240–276–6344, birdr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: August 1, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16784 Filed 8–6–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing in the U.S. 

FOR FURTHER INFORMATION CONTACT: 

Licensing information may be obtained 

by emailing the indicated licensing 

contact at the National Heart, Lung, and 

Blood, Office of Technology Transfer 

and Development Office of Technology 

Transfer, 31 Center Drive, Room 4A29, 

MSC2479, Bethesda, MD 20892–2479; 

telephone: 301–402–5579. A signed 


daltland on DSKBBV9HB2PROD with NOTICES